Dorzolamide Adco 20 mg Eye drops solution
PDF Leaflet Revision Date: 15 October 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of elevated intraocular pressure in glaucoma and ocular hypertension.
Dosage (summary)
1 drop in affected eye(s) 3 times daily as monotherapy; 2 times daily with beta-blockers.
Special Populations
- Paediatric population
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy; unknown if excreted in breast milk.
Key Drug Interactions
- Timolol
- Betaxolol
- Oral carbonic anhydrase inhibitors
Contraindications
- Hypersensitivity to dorzolamide
- Moderate to severe renal impairment
Common side effects
- Burning and stinging eyes
- Headache
- Dizziness
- Conjunctivitis
Counselling Points
- Use with caution in patients with renal calculi history
- Discontinue if serious reactions occur
- Administer other eye drops 10 mins apart
Serious warnings
- Risk of severe allergic reactions
- Caution in hepatic impairment
- Potential for urolithiasis
Important Disclaimer
The Dorzolamide Adco 20 mg Eye drops solution professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
